Table 1 Lymphocyte subpopulations from control lymph nodes, tonsils and reactive lymph nodes to head and neck carcinoma
Control | lymph | Reactive lymph nodes to lead | ||||||
|---|---|---|---|---|---|---|---|---|
nodes | Tonsils | and neck carcinoma | ||||||
ANTIGEN | N | Mean ± | N | Mean ± | P a) (Tonsil | N | P a) (reactive | |
SD | SD | Vs control) | Mean ± SD | Vs control) | ||||
CD7 | 27 | 68 ± 10 | 9 | 48 ± 11 | 0.0002 | 62 | 62 ± 11 | 0.01 |
CD19 | 26 | 24 ± 10 | 9 | 40 ± 15 | 0.004 | 63 | 30 ± 11 | 0.05 |
CD4 | 26 | 58 ± 10 | 9 | 42 ± 10 | 0.0005 | 65 | 56 ± 12 | NS |
CD8 | 27 | 12 ± 5 | 9 | 8 ± 1 | 0.002 | 65 | 9 ± 4 | 0.03 |
CD45RA | 28 | 63 ± 9 | 9 | 54 ± 17 | NS | 64 | 58 ± 12 | NS |
CD45RO | 28 | 29 ± 8 | 9 | 31 ± 9 | NS | 63 | 33 ± 10 | NS |
CD7/CD45RA | 25 | 37 ± 14 | 9 | 16 ± 4 | 0.0004 | 60 | 29 ± 10 | 0.004 |
CD7/CD45RO | 26 | 24 ± 8 | 9 | 27 ± 9 | NS | 60 | 28 ± 8 | NS |
CD69 | 8 | 14 ± 12 | 9 | 29 ± 10 | 0.02 | 14 | 23 ± 10 | NS |
CD3/CD69 | 7 | 12 ± 11 | 9 | 21 ± 10 | NS | 14 | 19 ± 8 | NS |